Relevance of hydroxyproline excretion to bone metastasis in breast cancer.

por Gielen, F., Dequeker, J., Drochmans, A., Wildiers, J., Merlevede, M.
Publicado 1976

Doxorubicin vs epirubicin, report of a second-line randomized phase II/III study in advanced breast cancer. EORTC Breast Cancer Cooperative Group.

por Bontenbal, M., Andersson, M., Wildiers, J., Cocconi, G., Jassem, J., Paridaens, R., Rotmensz, N., Sylvester, R., Mouridsen, H. T., Klijn, J. G., van Oosterom, A. T.
Publicado 1998

Assessment of bone response to systemic therapy in an EORTC trial: preliminary experience with the use of collagen cross-link excretion

por Vinholes, J, Coleman, R, Lacombe, D, Rose, C, Tubiana-Hulin, M, Bastit, P, Wildiers, J, Michel, J, Leonard, R, Nortier, J, Mignolet, F, Ford, J
Publicado 1999